Report cover image

Global Spatial Omics Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 204 Pages
SKU # APRC20361778

Description

Summary

According to APO Research, The global Spatial Omics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Spatial Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Spatial Omics include Akoya Biosciences, Biognosys AG, BioSpyder Technologies, Bio-Techne, Brooks Automation, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics and Dovetail Genomics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Spatial Omics, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Spatial Omics, also provides the revenue of main regions and countries. Of the upcoming market potential for Spatial Omics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Spatial Omics revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Spatial Omics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Spatial Omics revenue, projected growth trends, production technology, application and end-user industry.

Spatial Omics Segment by Company

Akoya Biosciences
Biognosys AG
BioSpyder Technologies
Bio-Techne
Brooks Automation
Bruker Corporation
Danaher Corporation
Diagenode Diagnostics
Dovetail Genomics
IonPath
Nanostring Technologies
PerkinElmer
Rebus Biosystems
S2 Genomics
Seven Bridges Genomics
Vizgen Corporation
Spatial Omics Segment by Type

Spatial Transcriptomic
Spatial Genomics
Spatial Proteomics
Spatial Omics Segment by Application

Laboratory
Research Institutions
Other
Spatial Omics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spatial Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Omics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Spatial Omics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Spatial Omics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spatial Omics revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

204 Pages
1 Market Overview
1.1 Product Definition
1.2 Spatial Omics Market by Type
1.2.1 Global Spatial Omics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Spatial Transcriptomic
1.2.3 Spatial Genomics
1.2.4 Spatial Proteomics
1.3 Spatial Omics Market by Application
1.3.1 Global Spatial Omics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Research Institutions
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Spatial Omics Market Dynamics
2.1 Spatial Omics Industry Trends
2.2 Spatial Omics Industry Drivers
2.3 Spatial Omics Industry Opportunities and Challenges
2.4 Spatial Omics Industry Restraints
3 Global Growth Perspective
3.1 Global Spatial Omics Market Perspective (2020-2031)
3.2 Global Spatial Omics Growth Trends by Region
3.2.1 Global Spatial Omics Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Spatial Omics Market Size by Region (2020-2025)
3.2.3 Global Spatial Omics Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Spatial Omics Revenue by Players
4.1.1 Global Spatial Omics Revenue by Players (2020-2025)
4.1.2 Global Spatial Omics Revenue Market Share by Players (2020-2025)
4.1.3 Global Spatial Omics Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Spatial Omics Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Spatial Omics Key Players Headquarters & Area Served
4.4 Global Spatial Omics Players, Product Type & Application
4.5 Global Spatial Omics Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Spatial Omics Market CR5 and HHI
4.6.3 2024 Spatial Omics Tier 1, Tier 2, and Tier 3
5 Spatial Omics Market Size by Type
5.1 Global Spatial Omics Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Spatial Omics Revenue by Type (2020-2031)
5.3 Global Spatial Omics Revenue Market Share by Type (2020-2031)
6 Spatial Omics Market Size by Application
6.1 Global Spatial Omics Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Spatial Omics Revenue by Application (2020-2031)
6.3 Global Spatial Omics Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Akoya Biosciences
7.1.1 Akoya Biosciences Comapny Information
7.1.2 Akoya Biosciences Business Overview
7.1.3 Akoya Biosciences Spatial Omics Revenue and Gross Margin (2020-2025)
7.1.4 Akoya Biosciences Spatial Omics Product Portfolio
7.1.5 Akoya Biosciences Recent Developments
7.2 Biognosys AG
7.2.1 Biognosys AG Comapny Information
7.2.2 Biognosys AG Business Overview
7.2.3 Biognosys AG Spatial Omics Revenue and Gross Margin (2020-2025)
7.2.4 Biognosys AG Spatial Omics Product Portfolio
7.2.5 Biognosys AG Recent Developments
7.3 BioSpyder Technologies
7.3.1 BioSpyder Technologies Comapny Information
7.3.2 BioSpyder Technologies Business Overview
7.3.3 BioSpyder Technologies Spatial Omics Revenue and Gross Margin (2020-2025)
7.3.4 BioSpyder Technologies Spatial Omics Product Portfolio
7.3.5 BioSpyder Technologies Recent Developments
7.4 Bio-Techne
7.4.1 Bio-Techne Comapny Information
7.4.2 Bio-Techne Business Overview
7.4.3 Bio-Techne Spatial Omics Revenue and Gross Margin (2020-2025)
7.4.4 Bio-Techne Spatial Omics Product Portfolio
7.4.5 Bio-Techne Recent Developments
7.5 Brooks Automation
7.5.1 Brooks Automation Comapny Information
7.5.2 Brooks Automation Business Overview
7.5.3 Brooks Automation Spatial Omics Revenue and Gross Margin (2020-2025)
7.5.4 Brooks Automation Spatial Omics Product Portfolio
7.5.5 Brooks Automation Recent Developments
7.6 Bruker Corporation
7.6.1 Bruker Corporation Comapny Information
7.6.2 Bruker Corporation Business Overview
7.6.3 Bruker Corporation Spatial Omics Revenue and Gross Margin (2020-2025)
7.6.4 Bruker Corporation Spatial Omics Product Portfolio
7.6.5 Bruker Corporation Recent Developments
7.7 Danaher Corporation
7.7.1 Danaher Corporation Comapny Information
7.7.2 Danaher Corporation Business Overview
7.7.3 Danaher Corporation Spatial Omics Revenue and Gross Margin (2020-2025)
7.7.4 Danaher Corporation Spatial Omics Product Portfolio
7.7.5 Danaher Corporation Recent Developments
7.8 Diagenode Diagnostics
7.8.1 Diagenode Diagnostics Comapny Information
7.8.2 Diagenode Diagnostics Business Overview
7.8.3 Diagenode Diagnostics Spatial Omics Revenue and Gross Margin (2020-2025)
7.8.4 Diagenode Diagnostics Spatial Omics Product Portfolio
7.8.5 Diagenode Diagnostics Recent Developments
7.9 Dovetail Genomics
7.9.1 Dovetail Genomics Comapny Information
7.9.2 Dovetail Genomics Business Overview
7.9.3 Dovetail Genomics Spatial Omics Revenue and Gross Margin (2020-2025)
7.9.4 Dovetail Genomics Spatial Omics Product Portfolio
7.9.5 Dovetail Genomics Recent Developments
7.10 IonPath
7.10.1 IonPath Comapny Information
7.10.2 IonPath Business Overview
7.10.3 IonPath Spatial Omics Revenue and Gross Margin (2020-2025)
7.10.4 IonPath Spatial Omics Product Portfolio
7.10.5 IonPath Recent Developments
7.11 Nanostring Technologies
7.11.1 Nanostring Technologies Comapny Information
7.11.2 Nanostring Technologies Business Overview
7.11.3 Nanostring Technologies Spatial Omics Revenue and Gross Margin (2020-2025)
7.11.4 Nanostring Technologies Spatial Omics Product Portfolio
7.11.5 Nanostring Technologies Recent Developments
7.12 PerkinElmer
7.12.1 PerkinElmer Comapny Information
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Spatial Omics Revenue and Gross Margin (2020-2025)
7.12.4 PerkinElmer Spatial Omics Product Portfolio
7.12.5 PerkinElmer Recent Developments
7.13 Rebus Biosystems
7.13.1 Rebus Biosystems Comapny Information
7.13.2 Rebus Biosystems Business Overview
7.13.3 Rebus Biosystems Spatial Omics Revenue and Gross Margin (2020-2025)
7.13.4 Rebus Biosystems Spatial Omics Product Portfolio
7.13.5 Rebus Biosystems Recent Developments
7.14 S2 Genomics
7.14.1 S2 Genomics Comapny Information
7.14.2 S2 Genomics Business Overview
7.14.3 S2 Genomics Spatial Omics Revenue and Gross Margin (2020-2025)
7.14.4 S2 Genomics Spatial Omics Product Portfolio
7.14.5 S2 Genomics Recent Developments
7.15 Seven Bridges Genomics
7.15.1 Seven Bridges Genomics Comapny Information
7.15.2 Seven Bridges Genomics Business Overview
7.15.3 Seven Bridges Genomics Spatial Omics Revenue and Gross Margin (2020-2025)
7.15.4 Seven Bridges Genomics Spatial Omics Product Portfolio
7.15.5 Seven Bridges Genomics Recent Developments
7.16 Vizgen Corporation
7.16.1 Vizgen Corporation Comapny Information
7.16.2 Vizgen Corporation Business Overview
7.16.3 Vizgen Corporation Spatial Omics Revenue and Gross Margin (2020-2025)
7.16.4 Vizgen Corporation Spatial Omics Product Portfolio
7.16.5 Vizgen Corporation Recent Developments
8 North America
8.1 North America Spatial Omics Revenue (2020-2031)
8.2 North America Spatial Omics Revenue by Type (2020-2031)
8.2.1 North America Spatial Omics Revenue by Type (2020-2025)
8.2.2 North America Spatial Omics Revenue by Type (2026-2031)
8.3 North America Spatial Omics Revenue Share by Type (2020-2031)
8.4 North America Spatial Omics Revenue by Application (2020-2031)
8.4.1 North America Spatial Omics Revenue by Application (2020-2025)
8.4.2 North America Spatial Omics Revenue by Application (2026-2031)
8.5 North America Spatial Omics Revenue Share by Application (2020-2031)
8.6 North America Spatial Omics Revenue by Country
8.6.1 North America Spatial Omics Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Spatial Omics Revenue by Country (2020-2025)
8.6.3 North America Spatial Omics Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Spatial Omics Revenue (2020-2031)
9.2 Europe Spatial Omics Revenue by Type (2020-2031)
9.2.1 Europe Spatial Omics Revenue by Type (2020-2025)
9.2.2 Europe Spatial Omics Revenue by Type (2026-2031)
9.3 Europe Spatial Omics Revenue Share by Type (2020-2031)
9.4 Europe Spatial Omics Revenue by Application (2020-2031)
9.4.1 Europe Spatial Omics Revenue by Application (2020-2025)
9.4.2 Europe Spatial Omics Revenue by Application (2026-2031)
9.5 Europe Spatial Omics Revenue Share by Application (2020-2031)
9.6 Europe Spatial Omics Revenue by Country
9.6.1 Europe Spatial Omics Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Spatial Omics Revenue by Country (2020-2025)
9.6.3 Europe Spatial Omics Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Spatial Omics Revenue (2020-2031)
10.2 China Spatial Omics Revenue by Type (2020-2031)
10.2.1 China Spatial Omics Revenue by Type (2020-2025)
10.2.2 China Spatial Omics Revenue by Type (2026-2031)
10.3 China Spatial Omics Revenue Share by Type (2020-2031)
10.4 China Spatial Omics Revenue by Application (2020-2031)
10.4.1 China Spatial Omics Revenue by Application (2020-2025)
10.4.2 China Spatial Omics Revenue by Application (2026-2031)
10.5 China Spatial Omics Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Spatial Omics Revenue (2020-2031)
11.2 Asia Spatial Omics Revenue by Type (2020-2031)
11.2.1 Asia Spatial Omics Revenue by Type (2020-2025)
11.2.2 Asia Spatial Omics Revenue by Type (2026-2031)
11.3 Asia Spatial Omics Revenue Share by Type (2020-2031)
11.4 Asia Spatial Omics Revenue by Application (2020-2031)
11.4.1 Asia Spatial Omics Revenue by Application (2020-2025)
11.4.2 Asia Spatial Omics Revenue by Application (2026-2031)
11.5 Asia Spatial Omics Revenue Share by Application (2020-2031)
11.6 Asia Spatial Omics Revenue by Country
11.6.1 Asia Spatial Omics Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Spatial Omics Revenue by Country (2020-2025)
11.6.3 Asia Spatial Omics Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Spatial Omics Revenue (2020-2031)
12.2 SAMEA Spatial Omics Revenue by Type (2020-2031)
12.2.1 SAMEA Spatial Omics Revenue by Type (2020-2025)
12.2.2 SAMEA Spatial Omics Revenue by Type (2026-2031)
12.3 SAMEA Spatial Omics Revenue Share by Type (2020-2031)
12.4 SAMEA Spatial Omics Revenue by Application (2020-2031)
12.4.1 SAMEA Spatial Omics Revenue by Application (2020-2025)
12.4.2 SAMEA Spatial Omics Revenue by Application (2026-2031)
12.5 SAMEA Spatial Omics Revenue Share by Application (2020-2031)
12.6 SAMEA Spatial Omics Revenue by Country
12.6.1 SAMEA Spatial Omics Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Spatial Omics Revenue by Country (2020-2025)
12.6.3 SAMEA Spatial Omics Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.